All Publications

Pages

1. • Journal article

   • 

   Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.

   Fiaccadori, Valeria Neven, Anouk Fortpied, Catherine Aurer, Igor André, Marc[UCL] Federico, Massimo Counsell, Nicholas Phillips, Elizabeth H Clifton-Hadley, Laura Barrington, Sally F Illidge, Timothy Radford, John Raemaekers, John M M (2023) British journal of haematology — Vol. 200, no. 6, p. 731-739 (2023)
2. • Speech

   • 

   Palifermin treatment in patients receiving high dose melphalan or BEAM prior to autologous peripheral blood stem-cell transplantation.

   Sonet, Anne Bries, G. Meulemans, N. Van Hoof, A. Steel, E. André, Marc Ferrant, Augustin Straetmans, N. Zachee, P. Robin, V. Demuynck, H. Noens, L. Bosly, André[UCL] Delforge, M.[UCL] Bron, D. (2006) 48th Annual Meeting of the American-Society-of-Hematology — Orlando (Fl)
3. • Journal article

   • 

   Long term results after 3 courses of ABVD plus subtotal nodal radiotherapy in 188 adult patients with stage I, II and IIA Hodgkin lymphoma

   Brice, P André, Marc[UCL] Franchi-Rezgui, P Bisaoli, I Hennequin, C (2008) Clinical Medicine : Blood disorders — Vol. 1, p. 1-5 (2008)
4. • Speech

   • 

   Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.

   Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) —
5. • Journal article

   • 

   Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma Trials

   Meignan, Michel Itti, Emmanuel Bardet, Stephane Lumbroso, Jean Edeline, Veronique Olivier, Pierre Vander Borght, Thierry[UCL] Reman, Oumedaly Karcher, Gilles Mundler, Olivier Mounier, Nicolas Ricci, Romain Federico, Massimo Raemaekers, John André, Marc (2009) Journal of Clinical Oncology — Vol. 27, no. 16, p. 2739-41 (2009)
6. • Journal article

   • 

   Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

   Eichenauer, Dennis A. Engert, Andreas André, Marc[UCL] Federico, Massimo Illidge, Tim Hutchings, Martin Ladetto, Marco ESMO Guidelines Working Group (2014) Annals of Oncology — Vol. 25, no. suppl. 3, p. iii70-iii75 (2014)
7. • Journal article

   • 

   Ovarian cancer associated with carcinomatous meningitis: a case report and review of the literature.

   Decelle, L D'Hondt, Lionel[UCL] André, Marc[UCL] Delree, P Calicis, B Lonchay, C Ide, C Canon, J-L (2007) International journal of gynecological cancer : official journal of the International Gynecological Cancer Society — Vol. 17, no. 5, p. 1136-40 (2007)
8. • Journal article

   • 

   Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment andfollow-up

   Tilly, H. Vitolo, U. Walewski, J. Da silva, M.G. Shpilberg, O. André, Marc[UCL] Pfreundschuh, M. Dreyling, M. (2012) Annals of Oncology — Vol. 23, Suppl. 7, p. vii78-vii82 (2012)
9. • Journal article

   • 

   Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P mutated diffuse large B-cell lymphoma: analysis of 361 cases.

   Dubois, Sydney Viailly, Pierre-Julien Bohers, Elodie Bertrand, Philippe Ruminy, Philippe Marchand, Vinciane Maingonnat, Catherine Mareschal, Sylvain Picquenot, Jean-Michel Penther, Dominique Jais, Jean-Philippe Tesson, Bruno Peyrouze, Pauline Figeac, Martin Desmots, Fabienne Fest, Thierry Haioun, Corinne Lamy, Thierry Copie-Bergman, Christiane Fabiani, Bettina Delarue, Richard Peyrade, Frederic André, Marc[UCL] Ketterer, Nicolas Leroy, Karen Salles, Gilles Molina, Thierry J Tilly, Herve Jardin, Fabrice (2017) Clinical Cancer Research — Vol. 23, no. 9, p. 2232-2244 (2017)
10. • Journal article

    • 

    Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.

    Coiffier, Bertrand Osmanov, Evgenii A Hong, Xiaonan Scheliga, Adriana Mayer, Jiri Offner, Fritz Rule, Simon Teixeira, Adriana Walewski, Jan de Vos, Sven Crump, Michael Shpilberg, Ofer Esseltine, Dixie-Lee Zhu, Eugene Enny, Christopher Theocharous, Panteli van de Velde, Helgi Elsayed, Yusri A Zinzani, Pier Luigi André, Marc[UCL] (2011) The Lancet Oncology — Vol. 12, no.8, p. 773-84 (2011)
11. • Journal article

    • 

    IBRUTINIB AND ATRIAL FIBRILLATION: A BELGIAN EXPERT CONSENSUS PAPER

    Vandenbriele, C Van der Linden, L Van Aelst, L Schwagten, P Van Heuverswyn, F Meers, S Galle, V Van Nieuwenhuyse, T Wu, K André, Marc[UCL] Hermans, C Janssens, A (2021) Belgian Journal of Hematology — Vol. 12, no.4, p. 155-164 (2021)
12. • Journal article

    • 

    Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA.

    Le Gouill, Steven Ghesquieres, Herve Obéric, Lucie Morschhauser, Franck Tilly, Herve Ribrag, Vincent Lamy, Thierry Thieblemont, Catherine Maisonneuve, Herve Gerard Gressin, Remy Bouabdallah, Krimo Haioun, Corinne Damaj, Gandhi Fornecker, Luc-Matthieu Bouabdallah, Reda Feugier, Pierre Sibon, David Cartron, Guillaume Bonnet, Christophe André, Marc[UCL] Chartier, Loic Ruminy, Philippe Kraeber-Bodere, F Bodet-Milin, C Berriolo-Riedinger, Alina Briere, Josette Jais, Jean-Philippe Molina, Thierry Itti, Emmanuel Casasnovas, Olivier (2021) Blood — Vol. 137, no. 17, p. 2307-2320 (2021)
13. • Journal article

    • 

    High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies.

    Van Den Neste, Eric[UCL] Michaux, Lucienne[UCL] Layios, Nathalie[UCL] Costantini, Sabrina[UCL] Francart, Julie[UCL] Lambert, Catherine[UCL] Sonet, Anne[UCL] André, Marc Robert, Annie[UCL] Ferrant, Augustin[UCL] (2004) Annals of Hematology — Vol. 83, no. 6, p. 356-363 (2004)
14. • Journal article

    • 

    Unmet needs in the scientific approach to older patients with lymphoma.

    Bron, Dominique Aurer, Igor André, Marc[UCL] Bonnet, Christophe Caballero, Dolores Falandry, Claire Kimby, Eva Soubeyran, Pierre Zucca, Emanuele Bosly, André[UCL] Coiffier, Bertrand (2017) Haematologica : the hematology journal — Vol. 102, no. 6, p. 972-975 (2017)
15. • Journal article

    • 

    A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells.

    Jacquy, C Sorée, A Lambert, F. Bosly, André[UCL] Ferrant, Augustin[UCL] André, Marc[UCL] Parma, J Kentos, A. Martiat, P. (2000) British journal of haematology — Vol. 110, no. 3, p. 631-637 (2000)
16. • Speech

    • 

    Density irregularities in the plasmasphere boundary layer: Cluster observations in the dusk sector

    Decreau, PME Le Guirriec, E Rauch, JL Trotignon, JG Canu, P Darrouzet, F Lemaire, Joseph[UCL] Sedgemore, F André, Marc (2005) 2nd World Space Congress/34th COSPAR Scientific Assembly — HOUSTON(Tx)
17. • Journal article

    • 

    Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)

    Herrera, Alex F. Ansell, Stephen M. Zinzani, Pier Luigi Radford, John Maddocks, Kami J. Pinto, Antonio Collins, Graham P. Bachanova, Veronika Bartlett, Nancy L. Bence-Bruckler, Isabelle Hamadani, Mehdi Kline, Justin Mayer, Jiri Savage, Kerry J. Advani, Ranjana H. Caimi, Paolo F. Casasnovas, René-Olivier Feldman, Tatyana A. Hess, Brian T. Bastos-Oreiro, Mariana Iyengar, Sunil Szomor, Árpád Townsend, William André, Marc[UCL] Dyczkowski, Jerzy Eisen, Sandy Urban, Andrzej Pantano, Serafino Cruz, Hans G. Wang, Luqiang Negievich, Yanina Wuerthner, Jens Carlo-Stella, Carmelo (2022) Blood — Vol. 140, no. Suppl 1, p. 3673-3677 (2022)
18. • Journal article

    • 

    Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.

    Salles, Gilles Duell, Johannes González Barca, Eva Tournilhac, Olivier Jurczak, Wojciech Liberati, Anna Marina Nagy, Zsolt Obr, Aleš Gaidano, Gianluca André, Marc[UCL] Kalakonda, Nagesh Dreyling, Martin Weirather, Johannes Dirnberger-Hertweck, Maren Ambarkhane, Sumeet Fingerle-Rowson, Günter Maddocks, Kami (2020) The Lancet. Oncology — Vol. 21, no. 7, p. 978-988 (2020)
19. • Journal article

    • 

    BHS GUIDELINES FOR THE MANAGEMENT OF SMALL LYMPHOCYTIC LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA, ANNO 2024

    Janssens, A André, Marc[UCL] (2023) Belgian Journal of Hematology — Vol. 14, no.7, p. 278-303 (2023)
20. • Journal article

    • 

    High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline.

    Rossi, Cédric André, Marc[UCL] Dupuis, Jehan Morschhauser, Franck Joly, Bertrand Lazarovici, Julien Ghesquières, Hervé Stamatoullas, Aspasia Nicolas-Virelizier, Emmanuelle Feugier, Pierre Gac, Anne-Claire Moatti, Hannah Fornecker, Luc-Matthieu Deau, Bénédicte Joubert, Clémentine Fortpied, Catherine Raemaekers, John Federico, Massimo Kanoun, Salim Meignan, Michel Traverse-Glehen, Alexandra Cottereau, Anne-Ségolène Casasnovas, René-Olivier (2022) Haematologica — Vol. 107, no. 12, p. 2897-2904 (2022)
21. • Journal article

    • 

    Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

    André, Marc[UCL] Girinsky, Théodore Federico, Massimo Reman, Oumédaly Fortpied, Catherine Gotti, Manuel Casasnovas, Olivier Brice, Pauline van der Maazen, Richard Re, Alessandro Edeline, Véronique Fermé, Christophe van Imhoff, Gustaaf Merli, Francesco Bouabdallah, Réda Sebban, Catherine Specht, Lena Stamatoullas, Aspasia Delarue, Richard Fiaccadori, Valeria Bellei, Monica Raveloarivahy, Tiana Versari, Annibale Hutchings, Martin Meignan, Michel Raemaekers, John (2017) Journal of Clinical Oncology — Vol. 35, no. 16, p. 1786-1794 (2017)
22. • Journal article

    • 

    The European Hematology Association Roadmap for European Hematology Research: a consensus document.

    Engert, Andreas Balduini, Carlo Brand, Anneke Coiffier, Bertrand Cordonnier, Catherine Döhner, Hartmut de Wit, Thom Duyvené Eichinger, Sabine Fibbe, Willem Green, Tony de Haas, Fleur Iolascon, Achille Jaffredo, Thierry Rodeghiero, Francesco Salles, Gilles Schuringa, Jan Jacob EHA Roadmap for European Hematology Research André, Marc[UCL] (2016) Haematologica : the hematology journal — Vol. 101, no.2, p. 115-208 (2016)
23. • Journal article

    • 

    Hematopoietic stem cell apheresis procedure in a context of related allogeneic transplant for acute myeloid leukemia: unexpected outcome, medical emergency and ethical issue.

    Bourgeois, Marc[UCL] Sonet, Anne[UCL] Botson, Françoise[UCL] Graux, Carlos[UCL] Fabry, Annick[UCL] André, Marc[UCL] Deneys, Véronique[UCL] (2017) Haematologica — Vol. 102, no. 3, p. e115-e116 (2017)
24. • Speech

    • 

    Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.

    André, Marc Mounier, N. Leleu, X Sonet, Anne Brice, P. Tilly, H. Coiffier, B. Bosly, André[UCL] Morel, Priscilla[UCL] Haioun, C. Gaulard, P. Gisselbrecht, C. (2001) —
25. • Speech

    • 

    Phase 2 Open-Label study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL

    Gladstone, D André, Marc[UCL] Zaucha, J Assouline, S Bellam, N Cascavilla , N Jourdan, E Panwalkar, A Patti, C Schulte, C Zaja , F Goswami, T Elgeioushi, N Streicher, K Bao, H Spaner, D (2014) 50th Annual Meeting of the American Society if Clinical Oncology — Chicago

Pages